A press release is a statement written in the third person that is distributed to the media, articulating to a journalist or editor how and why a particular person, c
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ompany, event, product or service is newsworthy.
Press releases conform to a short but established cookie-cutter format. They are emailed, faxed or snail mailed to m
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
dia including newspapers, radio and television stations. A press release is not written to be read by consumers. Target readers are reporters, editors and news direct
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ors – those who decide what is and isn’t news.
Why submit press releases to the media?
A good press release may be published as newsworthy, which gives you no-cost
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ublicity. A great press release will not only get published but will spark the creative kindling of a follow up story. Maybe even a feature story for print or broadca
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
t. Unlike advertising, news is accepted at face value and delivers many times the impact. This can attract prospects to you, position you as the obvious expert, pre-s
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ell your proposition, and propel your practice to rock star status.
How do you write a press release that gets read, published, and maybe even followed up with a sto
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
y?
Start by resisting the urge to give a sales pitch. Think like a reporter – just the facts. Remove your ego. Never say “I” or “we” unless it’s in a quote, and reme
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
mber a journalist has no interest in promoting your business. A reporter’s only goal is to write a story that will make editors happy and readers say, “Hmmm.”
Here,
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
n a nutshell, is the accepted format for a press release:
Company logo goes here
FOR IMMEDIATE RELEASE
Contact: John Smith
Tel.: 444-555-6666ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
Email: jsmith@email.com
HEADLINE GOES HERE IN UPPER CASE
Subhead Goes Here: Used To Expand Upon The Headline And Further Engage The
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Reporter In A Possible Story
The press release Lead goes here and gives the who, what, when, where and how of the story. Remember, no hype. Just the facts. Two to fo
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
r sentences should do.
Here you add support to the statements made in your headline, subhead and lead. Construct your case with solid material that demonstrates the
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
angle, or hook, you’ve taken. Tell why the reader should care about your announcement. Explain how you solve a problem.
Include a quote by you as president of your c
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
mpany. This gives your release a personal touch and brings your name front and center. Don’t be afraid to add a little “you” to your quote. This is your moment to por
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ray yourself as you want others to see you.
Now begin winding down your release with a sentence or two describing your company and what it is you do. This informatio
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
n is “boilerplate” and may be inserted into all press releases.
Standard code for the end of your press release is three # symbols centered beneath the last line.
I
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
keeping with one of my universal truths that says, “If you don’t ask, the answer is automatically no,” I like to add one final line such as: “To schedule an intervie
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
w with (your name), please call (your phone number),” just to run the thought of a possible story past the reporter.
To see an example of a press release I use to ge
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
erate thousands of dollars in no-cost publicity for my company, go to
Press Release.
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
